SCHEDULE: Yuling Luo Discloses 6.4% Stake in Alamar Biosciences

Yuling Luo has reported beneficial ownership of 6.4% of Alamar Biosciences' common stock as of June 30, 2026, including exercisable options and shares held by spouse.

Summary

• Yuling Luo has filed a Schedule 13G, reporting beneficial ownership of 4,528,718 shares of Alamar Biosciences, Inc. common stock.
• This represents 6.4% of the class of securities outstanding as of June 30, 2026.
• The reported shares include 1,440,501 shares issuable within 60 days of June 30, 2026, upon exercise of stock options.
• Additionally, 1,224,152 shares are held by Yuling Luo's spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, indicating a significant but not overwhelming ownership stake by a key individual, with clear disclosures about share allocation and future potential.

Positives

• Clear disclosure of a significant ownership stake (6.4%) by Yuling Luo.
• Transparency regarding shares issuable via stock options (1,440,501 shares).
• Disclosure of shares held by a spouse (1,224,152 shares), indicating shared financial interests.
• The filing is up-to-date as of June 30, 2026, with data based on the August 11, 2026, 10-Q filing.

Negatives

• No explicit negative information is present in this ownership filing.
• The filing does not provide financial performance data or strategic updates, limiting a full assessment.

Risks

• Potential for future share sales by Yuling Luo, which could impact stock price.
• Concentration of ownership could lead to significant influence over corporate decisions.
• The 1,440,501 shares issuable via options represent potential future dilution if exercised.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard for significant institutional investors or individuals who acquire more than 5% of a company's stock. This filing indicates Yuling Luo's substantial interest in Alamar Biosciences, a biotechnology company.

Related Party Transactions

• Yuling Luo's spouse holds 1,224,152 shares of Common Stock, indicating a related party holding.

Stakeholder Impact

• Shareholders: The disclosure provides transparency on a significant ownership block, which can influence market perception.
• Management: Yuling Luo's substantial stake may grant significant influence over board decisions and corporate strategy.

Next Steps

• Monitor future filings by Yuling Luo for any changes in ownership.
• Observe Alamar Biosciences' corporate actions and financial performance.

Key Dates

Keywords

Alamar Biosciences, Schedule 13G, Ownership, Beneficial Ownership, Stock Options, Insider Holding, Common Stock